Page last updated: 2024-08-21

arsenic trioxide and Squamous Cell Carcinoma of Head and Neck

arsenic trioxide has been researched along with Squamous Cell Carcinoma of Head and Neck in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Aminishakib, P; Asadi, M; Derakhshan, S; Farzaneh, P; Ganjibakhsh, M; Pirzadeh, F; Rahrotaban, S; Tavakoli Shiraji, S1
An, L; Li, X; Yang, X1
de Faria, GP; Dos Santos Ferreira, AC; Kwee, JK; Pereira, DL1
Boyko-Fabian, M; Budach, V; Distel, L; Niehr, F; Tinhofer, I1
Goux, D; Guillamin, M; Hamza-Chaffai, A; Khlifi, R; Sichel, F; Trabelsi, F1

Other Studies

5 other study(ies) available for arsenic trioxide and Squamous Cell Carcinoma of Head and Neck

ArticleYear
The effect of aflibercept and arsenic trioxide on the proliferation, migration and apoptosis of oral squamous cell carcinoma in vitro.
    Molecular biology reports, 2021, Volume: 48, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Endoglin; Humans; Mouth Neoplasms; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor B

2021
Arsenic trioxide induced endoplasmic reticulum stress in laryngeal squamous cell line Hep-2 cells.
    Auris, nasus, larynx, 2014, Volume: 41, Issue:1

    Topics: Activating Transcription Factor 4; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Head and Neck Neoplasms; Heat-Shock Proteins; Humans; Laryngeal Neoplasms; Oxides; Squamous Cell Carcinoma of Head and Neck; Transcription Factor CHOP

2014
Autophagy interplays with apoptosis and cell cycle regulation in the growth inhibiting effect of Trisenox in HEP-2, a laryngeal squamous cancer.
    Pathology oncology research : POR, 2015, Volume: 21, Issue:1

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Oxides; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck

2015
Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade.
    PloS one, 2014, Volume: 9, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Breaks, Double-Stranded; Drug Resistance, Neoplasm; ErbB Receptors; Head and Neck Neoplasms; Humans; Oxides; Protein Kinase Inhibitors; Squamous Cell Carcinoma of Head and Neck; Tumor Suppressor Protein p53

2014
Cytotoxicity and genotoxicity effects of arsenic trioxide on SQ20B human laryngeal carcinoma cells.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2017, Jul-05, Volume: 69, Issue:6

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Line, Tumor; Comet Assay; DNA Damage; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Oxides; Squamous Cell Carcinoma of Head and Neck

2017